CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

Malanchère-Brès, E; Payette, P J; Mancini, M; Tiollais, P; Davis, H L; Michel, M L

Malanchère-Brès, E; Payette, P J; Mancini, M; Tiollais, P; Davis, H L; Michel, M L.

Affiliation

Malanchère-Brès E; Unité de Recombinaison et Expression Génétique, INSERM U.163, Institut Pasteur, 28 rue du Docteur Roux, 75724 Paris Cédex 15, France.

J Virol ; 75(14): 6482-91, 2001 Jul.

Article in En | MEDLINE | ID: mdl-11413315

Subject(s)

Adjuvants, Immunologic/administration & dosage; Hepatitis B Surface Antigens/immunology; Hepatitis B, Chronic/prevention & control; Oligodeoxyribonucleotides/administration & dosage; Vaccination; Viral Hepatitis Vaccines/administration & dosage; Animals; Antibodies, Viral/blood; Disease Models, Animal; Hepatitis B Surface Antigens/blood; Hepatitis B virus/genetics; Hepatitis B virus/isolation & purification; Hepatitis B, Chronic/blood; Hepatitis B, Chronic/virology; Liver/virology; Mice; Mice, Inbred C57BL; Mice, Transgenic; RNA, Messenger/analysis; RNA, Viral/genetics; Vaccines, Synthetic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 4_TD Database: MEDLINE Main subject: Oligodeoxyribonucleotides / Viral Hepatitis Vaccines / Adjuvants, Immunologic / Vaccination / Hepatitis B, Chronic / Hepatitis B Surface Antigens Limits: Animals Language: En Journal: J Virol Year: 2001 Document type: Article

Fulltext

XML

PubMed Links

Search on Google